Medical cannabis Archives - Page 4 of 7 - Prohibition Partners

Skip to content Skip to footer

0 items - £0.00 0

Prohibition Partners

Prohibition Partners

Close

GeneralOctober 9, 2020

Synthetic cannabinoid firm halves workforce since 77% stock drop

GeneralOctober 2, 2020

Australian medical cannabis approvals rising despite COVID-19 disruptions

GeneralOctober 2, 2020

Europe is recording one million cannabis offences a year

GeneralSeptember 24, 2020

Product testing in Australia reveals inconsistencies over cannabinoid potency

GeneralSeptember 23, 2020

Prohibition Partners LIVE returns this November with global cannabis conference

GeneralSeptember 22, 2020

European Cannabis: Waking the Sleeping Giant

GeneralSeptember 18, 2020

Prohibition Partners Interviews Pharmin CEO Ana Kobalia

GeneralSeptember 14, 2020

Germany: Insured medicinal cannabis sales worth €75 million in the first half of 2020

GeneralSeptember 11, 2020

Recreational cannabis projects in Europe beginning to emerge

GeneralSeptember 11, 2020

Prohibition Partners interviews cannabinoid expert D’Arcy Bond from Newell Sciences

GeneralSeptember 10, 2020

US Congressional Committee Approves the Medical Cannabis Research Act

GeneralSeptember 4, 2020

Key insights from THE IMPACT SERIES: Disrupting Food